US Patent 11110095 Pyrimidine compounds as JAK kinase inhibitors

Patent 11110095 was granted and assigned to Theravance on September, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Theravance

Current Assignee

Theravance

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

111100950

Patent Inventor Names

Xiaojun Huang0

Paul R. Fatheree0

Ryan Hudson0

Anne-Marie Beausoleil0

Dante D. Podesto0

Jennifer Kozak0

Melissa Fleury0

Date of Patent

September 7, 2021

Patent Application Number

201910180

Date Filed

October 18, 2019

Patent abstract

The invention provides compounds of formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11110095 Pyrimidine compounds as JAK kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API